Farid Adrienne, the Chief Operations Officer of Century Therapeutics , Inc. (NASDAQ:IPSC), recently sold shares of the ...
PHILADELPHIA—Carr Douglas, Senior Vice President of Finance & Operations at Century Therapeutics , Inc. (NASDAQ:IPSC), recently sold 351 shares of the company's common stock. The shares were sold at a ...
LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...
26, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative In vitro data showcases CNTY-101’s ability to induce CD19-specific cytolysis of B-cells and potential to ...
ISELIN, N.J., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...
News Medical on MSN21h
Granzyme K identified as key trigger of complement system in autoimmune diseasesOur immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that ...
Roche Holding AG Akt-0.78% CHF230.86B ...
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback